phloretin has been researched along with Cancer of Skin in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tamoxifen is an estrogen receptor (ER) antagonist used as first-line chemotherapy in breast cancer." | 1.48 | Tamoxifen inhibits the proliferation of non‑melanoma skin cancer cells by increasing intracellular calcium concentration. ( Akatsuka, K; Hasegawa, G; Higo, N; Nakashima, Y; Shimonaka, M; Yokoe, Y, 2018) |
| "Pretreatment with phloretin on the dorsal skin of mice inhibited TPA-induced COX-2 expression in a dose-dependent manner." | 1.38 | Phloretin inhibits phorbol ester-induced tumor promotion and expression of cyclooxygenase-2 in mouse skin: extracellular signal-regulated kinase and nuclear factor-κB as potential targets. ( Kundu, JK; Shin, JW; Surh, YJ, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasegawa, G | 1 |
| Akatsuka, K | 1 |
| Nakashima, Y | 1 |
| Yokoe, Y | 1 |
| Higo, N | 1 |
| Shimonaka, M | 1 |
| Abkin, SV | 1 |
| Ostroumova, OS | 1 |
| Komarova, EY | 1 |
| Meshalkina, DA | 1 |
| Shevtsov, MA | 1 |
| Margulis, BA | 1 |
| Guzhova, IV | 1 |
| Shin, JW | 1 |
| Kundu, JK | 1 |
| Surh, YJ | 1 |
3 other studies available for phloretin and Cancer of Skin
| Article | Year |
|---|---|
Tamoxifen inhibits the proliferation of non‑melanoma skin cancer cells by increasing intracellular calcium concentration.
Topics: Antineoplastic Agents, Hormonal; Calcimycin; Calcium; Calcium Channels; Carcinoma, Squamous Cell; Ce | 2018 |
Phloretin increases the anti-tumor efficacy of intratumorally delivered heat-shock protein 70 kDa (HSP70) in a murine model of melanoma.
Topics: Animals; Cell Line, Tumor; Disease Models, Animal; Female; HSP70 Heat-Shock Proteins; Humans; Immuno | 2016 |
Phloretin inhibits phorbol ester-induced tumor promotion and expression of cyclooxygenase-2 in mouse skin: extracellular signal-regulated kinase and nuclear factor-κB as potential targets.
Topics: Animals; Anticarcinogenic Agents; Cyclooxygenase 2; Dose-Response Relationship, Drug; Down-Regulatio | 2012 |